← FDA DRUG APPROVALS

FDA ANDA · ANDA062339

STATROL

Sponsor: ALCON

APPLICATION
ANDA062339
TYPE
ANDA
ORIGINAL APPROVAL
1984-11-30
LATEST ACTION
1995-08-04
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

STATROLDiscontinued
NEOMYCIN SULFATE EQ 3.5MG BASE/ML, POLYMYXIN B SULFATE 16,250 UNITS/ML · SOLUTION/DROPS · OPHTHALMIC

Approval history

1995-08-04Manufacturing (CMC) · Supplement 7AP
1993-08-18Labeling · Supplement 6AP
1993-04-14Labeling · Supplement 5AP
1984-11-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →